Abstract:Purpose: Due to the high metastatic ability and poor prognosis of lung adenocarcinoma (LUAD), we identified novel non-coding RNAs, which constitute approximately 60% of human transcripts, as prognostic biomarkers and potential therapeutic targets for LUAD. Methods: In this study, we downloaded and analyzed microRNA (miRNA) datasets from The Cancer Genome Atlas (TCGA) to identify dysregulated miRNAs correlating with the overall survival (OS) of LUAD patients. miR-421, circ_0000567, and TMEM100 expression levels were examined by quantitative real-time polymerase chain reaction (qRT-PCR) in NSCLC tissues from 73 patients and adjacent normal tissues. Cell migration and invasion were assayed using wound healing and transwell assays. miR-421 target predictions were conducted using starBase, CircInteractome, circBank, TargetScan, miRanda, MirDB, miRpath, and Gene Expression Omnibus (GEO) databases. The circular structure and stability of circ_0000567 were verified by RNase R digestion and qRT-PCR using oligo(dT) and random primers. A luciferase reporter assay was used to evaluate the relationship between miR-421, circ_0000567, and TMEM100. Results: The miRNA panel associated with OS in patients with LUAD was screened according to the hazard ratio (HR) of miRNAs from high to low. Based on the correlation between these miRNAs and OS, as well as miRNA expression levels, miR-421 was selected for further outcome analysis. High miR-421 expression was an independent risk factor for shorter OS in 73 patients collected from our department. Bioinformatic analyses, luciferase reporter assays, and functional assays showed that circ_0000567 could act as a sponge for miR-421 and prevent it from directly targeting the 3'-untranslated region of TMEM100 mRNA and further degrading it in LUAD. miR-421 expression was significantly upregulated, while circ_0000567 and TMEM100 were downregulated in tumor tissues of LUAD, compared to their counterparts in normal tissues. Gain- and loss-of-function assays showed that miR-421 promoted LUAD cell migration and invasion. Overexpression of circ_0000567 inhibited migration and invasion, whereas co-transfection of circ_0000567 and miR-421 mimics partly counteracted this effect. TMEM100 was upregulated by enhanced circ_0000567 in LUAD cells, and the expression of TMEM100 was inversely proportional to miR-421, whereas it was directly proportional to circ_0000567 in 73 LUAD specimens, which confirmed the competitive endogenous RNA (ceRNA) network. Conclusion: Our findings suggest that miR-421 promotes the migration and invasion of lung adenocarcinoma via circ_0000567/miR-421/TMEM100 signaling and could be a prognostic biomarker for LUAD.

Hsa_circ_0000519 Promotes the Progression of Lung Adenocarcinoma Through the Hsa-Mir-1296-5p/dars Axis.

Hsa_circ_0001492 Regulates the Hsa-Mir-145-5p/ovarian Carcinoma Immunoreactive Antigen Domain 2 Axis to Promote the Progression of Lung Adenocarcinoma

Hsa_circ_0001492 Regulates the Hsa-Mir-1455p/ovarian Carcinoma Immunoreactive Antigen Domain 2 Axis to Promote the Progression of Lung Adenocarcinoma

hsa_circ_0000729, a potential prognostic biomarker in lung adenocarcinoma.

Circular RNA Hsa_circ_0000326 Acts As a Mir-338-3p Sponge to Facilitate Lung Adenocarcinoma Progression

Aberrant Expression of Hsa_circ_0025036 in Lung Adenocarcinoma and Its Potential Roles in Regulating Cell Proliferation and Apoptosis.

Overexpression of Hsa_circ_0008274 Inhibited the Progression of Lung Adenocarcinoma by Regulating HMGA2 Via Sponging Mir‐578

Hsa_circ_0006692 Promotes Lung Cancer Progression Via Mir-205-5p/cdk19 Axis

Circular RNA Microarray Expression Profile and Potential Function of Circ0005875 in Clear Cell Renal Cell Carcinoma.

Circ-AASDH Functions As the Progression of Early Stage Lung Adenocarcinoma by Targeting Mir-140-3p to Activate E2F7 Expression.

Circular RNA Hsa-Circ-000881 Suppresses the Progression of Lung Adenocarcinoma in Vitro Via a Mir-665/Prickle2 Axis.

Activation of circ_0072088/ miR ‐1261/ PIK3CA pathway accelerates lung adenocarcinoma progression

Hsa_circ_0001361 facilitates the progress of lung adenocarcinoma cells via targeting miR-525-5p/VMA21 axis

Circ-HMGA2 (hsa_circ_0027446) Promotes the Metastasis and Epithelial-Mesenchymal Transition of Lung Adenocarcinoma Cells Through the Mir-1236-3p/zeb1 Axis

Hsa_circ_0079929 in lung adenocarcinoma and its biological implications in lung adenocarcinoma progression

Upregulated circRNA hsa_circ_0071036 promotes tumourigenesis of pancreatic cancer by sponging miR-489 and predicts unfavorable characteristics and prognosis

Hsa_circ_0013958: a Circular RNA and Potential Novel Biomarker for Lung Adenocarcinoma

Hsa_circ_0003945 Promotes Progression of Hepatocellular Carcinoma by Mediating Mir‐34c‐5p/lgr4/β‐catenin Axis Activity

Circ_0000567/mir-421/Tmem100 Axis Promotes the Migration and Invasion of Lung Adenocarcinoma and is Associated with Prognosis.

Hsa_circ_0109320 Serves as a Novel Circular RNA Biomarker in Non-small Cell Lung Cancer by Promoting Metastasis

CircDUS2L (circ_0039908) promotes lung adenocarcinoma progression by upregulating PGAM1 by acting as a miR‐590‐5p molecular sponge